KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

KALV
KalVista Pharmaceuticals, Inc.US flagNASDAQ
27.00
USD
- -
- -
1.44BMarket Cap

KalVista Pharmaceuticals, Inc. (KALV) Stock Split History

Learn about KalVista Pharmaceuticals, Inc.'s most recent 1-for-14 basis stock split on November 22, 2016. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about KalVista Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2016-11-22
Split Ratio: 1:14
Price Before Split: $0.60
Price After Split: $0.04

Developer API

Get KALV split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/KALV

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 14.00 times fewer shares (a 1:14 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of KalVista Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2016-11-221:14Yes$0.60$0.04

About KalVista Pharmaceuticals, Inc.

Company overview and industry information

KalVista Pharmaceuticals, Inc. (KALV) operates in the Biotechnology industry. The recent 1-for-14 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to KalVista Pharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.